2023年美国风湿病学会(ACR)/美国胸科医师学会(CHEST)指南:系统性自身免疫性风湿病患者间质性肺病的筛查与监测
该指南针对类风湿关节炎、系统性硬化症、特发性炎性肌病、混合性结缔组织病和干燥病患者,就间质性肺病(ILD)的筛查与监测提出15条推荐。筛查方面条件性推荐肺功能检查(PFT)和胸部高分辨率计算机断层扫描(HRCT),条件性不推荐6分钟步行距离、胸部X线、步行血氧饱和度检测或支气管镜筛查,强烈不推荐外科肺活检筛查。监测方面条件性推荐PFT、胸部HRCT和步行血氧饱和度检测,条件性不推荐6分钟步行距离、胸部X线或支气管镜监测。
要点
- 筛查ILD条件性推荐PFT和胸部HRCT,强烈不推荐外科肺活检。
- 监测ILD条件性推荐PFT、胸部HRCT和步行血氧饱和度检测。
- 筛查与监测均条件性不推荐6分钟步行距离、胸部X线和支气管镜。
核心结论
- 该临床实践指南提出了ACR和CHEST认可的首个关于SARD患者ILD筛查与监测的推荐。
研究设计与样本
- 指南针对SARD患者ILD筛查与监测构建临床相关问题,进行系统文献综述,采用推荐分级的评估、制定与评价(GRADE)方法评价证据,由多学科临床专家和患者组成的投票小组对每条推荐的方向和强度达成共识。
主要发现
- 共制定15条推荐。
关键数值与推荐
- 对SARD患者ILD筛查条件性推荐PFT和胸部HRCT。
- 对SARD患者ILD筛查条件性不推荐6分钟步行距离、胸部X线、步行血氧饱和度检测或支气管镜。
- 对SARD患者ILD筛查强烈不推荐外科肺活检。
- 对SARD患者ILD监测条件性推荐PFT、胸部HRCT和步行血氧饱和度检测。
- 对SARD患者ILD监测条件性不推荐6分钟步行距离、胸部X线或支气管镜。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies, mixed connective tissue disease, and Sjögren disease. METHODS: We developed clinically relevant population, intervention, comparator, and outcomes questions related to screening and monitoring for ILD in patients with SARDs. A systematic literature review was performed, and the available evidence was rated using the Grading of Recommendations, Assessment, Development, and Evaluation methodology. A Voting Panel of interdisciplinary clinician experts and patients achieved consensus on the direction and strength of each recommendation. RESULTS: Fifteen recommendations were developed. For screening people with these SARDs at risk for ILD, we conditionally recommend pulmonary function tests (PFTs) and high-resolution computed tomography of the chest (HRCT chest); conditionally recommend against screening with 6-minute walk test distance (6MWD), chest radiography, ambulatory desaturation testing, or bronchoscopy; and strongly recommend against screening with surgical lung biopsy. We conditionally recommend monitoring ILD with PFTs, HRCT chest, and ambulatory desaturation testing and conditionally recommend against monitoring with 6MWD, chest radiography, or bronchoscopy. We provide guidance on ILD risk factors and suggestions on frequency of testing to evaluate for the development of ILD in people with SARDs. CONCLUSION: This clinical practice guideline presents the first recommendations endorsed by the American College of Rheumatology and American College of Chest Physicians for the screening and monitoring of ILD in people with SARDs.
引用
- Johnson SR, Bernstein EJ, Bolster MB, et al. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care Res (Hoboken). 2024. PMID: 38973729. doi:10.1002/acr.25347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。